Normalized Pre-Tax Income: A company's income before income tax expense smoothed out by removing non-recurring items.
Quantum Biopharma Ltd. (V.QNT) had Normalized Pre-Tax Income of -13.51M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
-13.51M |
|
-- |
|
-- |
|
-- |
|
-6.71M |
|
-- |
|
-13.51M |
|
|
Normalized Pre-Tax Income |
-13.51M |
-13.51M |
|
-13.51M |
|
-13.51M |
|
-13.51M |
|
-6.71M |
|
-6.53M |
|
3.02M |
|
3.02M |
|
-4.47 |
|
-4.47 |
|
| Balance Sheet Financials | |
-- |
|
-- |
|
-- |
|
21.16M |
|
-- |
|
-- |
|
-- |
|
18.33M |
|
2.83M |
|
-3.70M |
|
2.83M |
|
3.47M |
|
| Cash Flow Statement Financials | |
-8.59M |
|
-3.75M |
|
6.12M |
|
8.29M |
|
2.07M |
|
-6.22M |
|
1.58M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.78 |
|
-- |
|
-- |
|
-- |
|
1.11 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-8.59M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-477.10% |
|
364.66% |
|
-63.84% |
|
-477.10% |
|
0.82 |
|
-2.84 |
|
-2.84 |
|